Sean Kent

Articles by Sean Kent

104 KATSIS-1: Randomized Phase 3 Trial Evaluating KAT6 Inhibitor PF-07248144 (prifetrastat) Plus Fulvestrant in HR+HER2− Advanced/Metastatic Breast Cancer After Progression on CDK4/6 Inhibitor-Based Therapy

ByKevin Kalinsky, MD, MS,Rachel M. Layman,Antonio Giordano,Toru Mukohara,Yeon Hee Park,Geoffrey J. Lindeman,Giampaolo Bianchini,Alexandre de Nonneville,Véronique Diéras, MD,Sherko Kuemmel,Shusen Wang,Zhiming Shao,Sean Kent,Griffith M. Davis,Meng Li,Mafalda Oliveira

May 19th 2026

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Tucatinib Combo as Maintenance in HER2+ Breast Cancer

Novel Cancer Vaccine Plus Temozolomide Miss Primary End Point in Glioblastoma

Personalized Vaccines May Have Utility Across All Lung Cancer Stages

Considering Talquetamab and Emerging Bispecifics in R/R Multiple Myeloma

Transmucosal Patch Yields Pathologic Responses in Non-Invasive Oral Cancer